Public Company News

Antengene Announces the Study of Anti-CD24 Monoclonal Antibody ATG-031 Dosed Its First Patient in the United States

* The Phase I PERFORM trial, taking place at four clinical trial centers across the U.S., will evaluate the safety and preliminary efficacy of ATG-031 in patients withadvanced solid tumors or B-cell non-Hodgkin's lymphoma (B-NHL). * ATG-031, discovered and developed in-house by Antengene, is t...

2023-12-11 08:30 2468

SurplusGLOBAL Announces Participation in SEMICON JAPAN 2023 to Showcase the Legacy Parts Distribution Solutions

SEOUL, South Korea, Dec. 11, 2023 /PRNewswire/ -- SurplusGLOBAL, a global leader in the legacy semiconductor equipment industry, has announced its participation in the SEMICONJAPAN 2023 exhibition. The event is scheduled to take place fromDecember 13th to 15th, 2023, at the Tokyo Big Sight in Jap...

2023-12-11 08:00 3655

Samyang Corporation, Expansion of global market by launching two new industrial water treatment equipment

* Following ion exchange resin, RO membrane, and EDI have been released. Establishing three key materials for water treatment * Becoming a comprehensive solution provider through newly launched products and a new dedicated organization, "Water Solutions PU (Performance Unit)". SEOUL, South Kor...

2023-12-11 07:30 5109

USI Collaborates with Customer to Launch IP66-Rated Rugged Industrial Tablet, Meeting High Efficiency Demands for On-Site Work

SHANGHAI, Dec. 11, 2023 /PRNewswire/ -- USI (SSE: 601231) collaborates with a customer to launch a rugged industrial tablet with an IP66 rating, providing a reliable mobile solution for on-site professionals and line workers. This tablet has a 10-inch touch screen and barcode scanning functionali...

2023-12-11 07:00 4226

Dizal's Golidocitinib Pivotal Trial Demonstrates Superior and Durable Clinical Benefits for Patients with r/r PTCL in Oral Presentation at 2023 ASH

* Full analysis of multinational pivotal study results of golidocitinib in relapsed or refractory peripheral T-cell lymphoma (r/r PTCL) (JACKPOT8 PART B) simultaneously published inThe Lancet Oncology and presented in oral session at the 65th American Society of Hematology Annual Meeting and Ex...

2023-12-10 18:00 3267

CSRC and SSE receive APAC's largest real asset manager ESR Group's application of its public warehousing logistics REIT

New C-REIT focuses on "best-in-class" logistics facilities Backed by APAC's largest real asset manager, ESR Group's leading New Economy platform has approximatelyUS$69 billion of New Economy AUM and APAC's largest New Economy development workbook ofUS$13 billion Flagship C-REIT for ESR Group th...

2023-12-08 21:16 8722

WiMi Announced Augmented Reality Dynamic Image Recognition Based on Deep Convolutional Neural Networks

BEIJING, Dec. 8, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that the deep convolutional neural network(DCNN) was used as the core algorithm for image recognition, a...

2023-12-08 21:00 3567

Lanvin Group Holdings Limited to Hold Annual General Meeting on December 21, 2023

NEW YORK, Dec. 8, 2023 /PRNewswire/ -- Lanvin Group Holdings Limited (NYSE: LANV, the "Company" or "Lanvin Group"), a global luxury fashion group, today announced that it will hold its annual general meeting of the shareholders (the "AGM") virtually through a live webcast and teleconference onDec...

2023-12-08 19:43 5056

President Jokowi Applauds BRI's Empowerment of MSMEs at the UMKM EXPO(RT) BRILIANPRENEUR 2023

JAKARTA, Indonesia, Dec. 8, 2023 /PRNewswire/ -- PT Bank Rakyat Indonesia (BRI) Persero Tbk. (IDX: BBRI)marked its 128th anniversary with the UMKM EXPO(RT) BRILIANPRENEUR 2023, inaugurated by Indonesia's President, Joko Widodo (Jokowi), at theJakarta Convention Center from December 7 to 10. In hi...

2023-12-08 19:42 5321

Sinopec Highlights CCUS Achievements at COP 28 and Releases Its First 10-Year Performance Report on Supporting "Belt and Road" Initiative

DUBAI, UAE, Dec. 8, 2023 /PRNewswire/ -- China Petroleum & Chemical Corporation's (HKG: 0386, "Sinopec") has highlighted the key achievements in carbon capture, utilization, and storage (CCUS) and released the first 10-year performance report supporting the "Belt and Road" Initiative ("BRI") at t...

2023-12-08 19:18 4937

ChipMOS REPORTS 20.3% YoY INCREASE IN NOVEMBER 2023 REVENUE

HSINCHU, Dec. 8, 2023 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and NASDAQ: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT"), today reported a 20.3% year over year increase for i...

2023-12-08 19:00 4964

Lanvin Group Announces New CEO

NEW YORK, Dec. 8, 2023 /PRNewswire/ -- The board of Lanvin Group (NYSE: LANV) today announced thatJoann Cheng, the group's founding Chairman and Chief Executive Officer, has informed the board that she has decided to step down from her roles to pursue new endeavours outside the group. Consequentl...

2023-12-08 18:00 4369

WuXi Biologics Awarded Highest Platinum Medal by EcoVadis Sustainability Rating

* Ranked in top 1% of the over 100,000 companies evaluated * Recognized for outstanding performance across all areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement * Seen as a trusted partner by global clients for its strong sustainability commitment SHANGHAI, Dec. 8...

2023-12-08 17:40 4947

Hello Group Inc. Announces Unaudited Financial Results for the Third Quarter of 2023

BEIJING, Dec. 8, 2023 /PRNewswire/ -- Hello Group Inc. (NASDAQ: MOMO) ("Hello Group" or the "Company"), a leading mobile social and entertainment platform in China, today announced its unaudited financial results for the third quarter of 2023.    Third Quarter of 2023 Highlights * Net revenues...

2023-12-08 16:25 6039

Kindred Ventures- SK Networks-SoftBank Ventures Asia Present Global AI Forum in Seoul, South Korea.

* 'AI WAVE 2023': Shaping the Future of Industries with AI, Offering a Platform for Investment Insights * Steve Jang and Kanyi Maqubela, Kindred Ventures' Managing Partners, Led the Discussions with the Leading AI Startups from Silicon Valley and Held Fireside Chats with SK Networks and SoftB...

2023-12-08 15:23 6918

GDS Secures MYR1.27 Billion Syndicated Green Financing to Complete the Next Phase of Nusajaya Tech Park Data Center Campus Development

Company's largest syndicated green financing is recognized with "Best Property Deal" inSE Asia at the FinanceAsia Achievement Awards 2023 JOHOR BAHRU, Malaysia, Dec. 8, 2023 /PRNewswire/ -- GDS, a leading developer and operator of high-performance data centers, announced today that it has secure...

2023-12-08 14:55 7434

Inaugurating the UMKM EXPO(RT) BRILIANPRENEUR 2023, President Joko Widodo Applauds BRI's Support in Advancing MSMEs

JAKARTA, Indonesia, Dec. 8, 2023 /PRNewswire/ -- Indonesian President, Joko Widodo, graced the inauguration of BRI's UMKM EXPO(RT) BRILIANPRENEUR 2023, held at theJakarta Convention Center (JCC) on December 7, 2023. This event, also part of the bank's 128th anniversary celebrations, served as a p...

2023-12-08 14:16 6790

PharmaBlock Officially Joins United Nations Global Compact

NANJING, China, Dec. 8, 2023 /PRNewswire/ -- PharmaBlock Sciences (Nanjing), Inc. (Stock code: 300725.SZSE), a global, fully integrated CRDMO company, focusing on innovative chemistry and low-carbon manufacturing, has officially joined the United Nations Global Compact (UNGC), which not only affi...

2023-12-08 12:37 3117

iQIYI's Chief Content Officer at Asia TV Forum: Driving Premium Chinese Content to Global Prominence

BEIJING, Dec. 8, 2023 /PRNewswire/ -- iQIYI, an innovative market-leading online entertainment service inChina, attended the 2023 Asia TV Forum (ATF) held inSingapore from December 5 to 8. WANG Xiaohui, Chief Content Officer of iQIYI, joined a fireside chat onsite and emphasized the platform's un...

2023-12-08 12:10 3903

CStone Announces NMPA Approval of Sugemalimab as First-line Treatment for Esophageal Squamous Cell Carcinoma

* Sugemalimab is the world's first anti-PD-L1 monoclonal antibody approved for use in combination with fluorouracil and platinum-based chemotherapy for unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma. * This marks the 13th NDA approval obtained by CSt...

2023-12-08 12:10 7561